Cardinal Health: Attractive Long-Term Investment At 10.0x Forward P/E

Jan. 15, 2022 2:41 AM ETCardinal Health, Inc. (CAH) StockCAH8 Comments
Cameron Smith, CFA
2.98K Followers

Summary

  • Cardinal Health looks like a great long-term value investment current trading at 10.0x forward P/E.
  • The company does a good job returning cash to shareholders through share repurchases of 2.1% annually in addition to the current 3.76% dividend yield.
  • The company recently announced a new $3 billion share repurchase plan over the next 3 years which represents 20.4% of the company's shares.
  • A discounted cash flow valuation estimates a $66.86 intrinsic value and takes into account the still outstanding opioid settlement cash payments.

Sports girl who wants to start the new year 2022. Concept of new professional achievements in the new year and success

Galeanu Mihai/iStock via Getty Images

Cardinal Health (NYSE:CAH) has had a rough last few years staring with the opioid scandal but continues to look like a highly attractive long-term investment trading at only 10.0x forward P/E. The company fell hard

This article was written by

2.98K Followers
Through always enjoying the concepts of value creation and business management it has allowed me to explore potential investments at an academic and strategic level. My investment ideas are presented through two sides; with the most important being financial performance and the second most important being valuation. In my opinion, if a company does not meet certain financial criteria, a valuation of that company can only mean something if you are investing in the senior debt at best or if you are purely speculating at worst. Focusing on return on invested capital (ROIC), I classify potential investments as either long-term/indefinite investments, medium-term investments, or value traps. 1) Long-term/Indefinite: ROIC of greater than 9% and able to grow intrinsic value 2) Medium-term: ROIC of 6 – 9% and able to maintain intrinsic value. 3) Value Traps: ROIC of less than 6% and not able to meet their cost of capital My investing philosophy stems from Warren Buffett’s focus on long-term moats and value creation while expanding to include potential growth opportunities from the approach of Peter Lynch. At heart, I am a long-term investor that looks to buy value opportunities at a 30 per cent discount to intrinsic value with the potential to earn over 9 per cent return on equity (ROE) adjusted for the equity value per share that is paid at purchase. I believe growth is always a subjective variable but can be estimated through a product of retained earnings and the companies return on equity given the variability of both in the past decade.Disclaimer: While the information and data presented in my articles are obtained from company documents and/or sources believed to be reliable, they have not been independently verified. The material is intended only as general information for your convenience, and should not in any way be construed as investment advice. I advise readers to conduct their own independent research to build their own independent opinions and/or consult a qualified investment advisor before making any investment decisions. I explicitly disclaim any liability that may arise from investment decisions you make based on my articles.

Analyst’s Disclosure:I/we have a beneficial long position in the shares of CAH either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

I have a long position in CAH at an average cost base of $54.66. Disclaimer: While the information and data presented in my articles are obtained from company documents and/or sources believed to be reliable, they have not been independently verified. The material is intended only as general information for your convenience, and should not in any way be construed as investment advice. I advise readers to conduct their own independent research to build their own independent opinions and/or consult a qualified investment advisor before making any investment decisions. I explicitly disclaim any liability that may arise from investment decisions you make based on my articles.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About CAH Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on CAH

Related Stocks

SymbolLast Price% Chg
CAH
--